Condition: Diabetes Mellitus, Type 1 · Sponsor: T1D Exchange, United States
The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind prescription decisions. The study will highlight the development and implementation an EMR-based Best Practice Advisory (BPA). The study will answer whether the EMR-based BPA can effectively reduce disparities. Additionally, it will explore why providers may not prescribe advanced diabetes technologies. Patients will also be surveyed to understand their perspectives on developing the EMR-based BPA.
This description comes directly from the study's public registry record.
Osagie Ebekozien, MD · 857-205-2388 · oebekozein@t1dexchange.org
Trevon Wright, MHA · 6178927564 · twright@t1dexchange.org
Always discuss trial participation with your own doctor first.
| T1D Exchange | Boston, Massachusetts, United States | Recruiting |
| T1D Exchange | Boston, Massachusetts, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06931275